Sookjin Lee

Chief Business Officer (CBO) | Ph.D.

A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.

[Clinical Review] Why WGS Achieves up to 44.4% Diagnostic Yield in NDD: Insights from a 100-Family Italian Study2026. 02. 20
Diagnostic Yield of WES in Infantile HCM with Normal CMA: A Case of PTPN11-associated Noonan Syndrome2026. 02. 13
Genetic Mechanisms of GDD with Normal MRI: WES Strategies to End the Diagnostic Odyssey2026. 02. 10
Prolonged Febrile Seizures and Developmental Plateau in a 7-Month-Old Infant: Beyond Simple Febrile Convulsions2026. 02. 09
Progressive Neurodevelopmental Regression and Refractory Epilepsy in a 36-Month-Old Female: A Clinical Correlation2026. 02. 09
Differential Diagnosis of Infantile Hypotonia: A Clinical Guide to Genetic Testing Integration2026. 02. 06